Chronic Migraine, Headache
Conditions
Keywords
neurofeedback mindfulness, headache management self-efficacy, chronic migraines, dependence behaviours, migraine severity
Brief summary
As the second phase of our study on migraine headaches and neurofeedback mindfulness, we will explore how chronic migraineurs will benefit from a long term practice (8 weeks) of neurofeedback mindfulness compared to a similar attention group and a waitlisted group. This randomized controlled trial will also explore if migrianuers could decrease their dependence on medicine intake after completion of the study.
Interventions
BEHAVIORALNeurofeedback Mindfulness
The participants will use a portable EEG headband (MUSE) which is a noninvasive tool for collecting EEG data. They will receive real-time EEG data given an audio feedback while doing their daily mindfulness practice.
BEHAVIORALAttention Task
The participants in this arm will use the portable EEG while listening to an audiobook. They will receive a summary of their brain activities after task completion on each day.
Sponsors
Saskatchewan Health Research Foundation
University of Saskatchewan
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* have a diagnosis of chronic migraine from a clinician or have met the criteria for a chronic migraine diagnosis based on ICHD-3 * reside in Saskatoon area * have a smartphone and internet connection for accessing the MUSE app * have no frequent background experience of meditation
Exclusion criteria
* Comorbidity of Raynaud's syndrome or diabetes * Current use of a preventative migraine treatment over 6 months
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Migraine Disability | 8 weeks | measured by Migraine Disability Assessment Scale (MIDAS) |
| Migraine Severity | 8 weeks | measured by Headache Impact Test-short form (HIT-6) |
| Headache management self-efficacy | 8 weeks | measured by Headache Management Self-Efficacy Scale |
| Dependence on medicine | 8 weeks | measured by Severity of Dependence Scale (SDS) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Anxiety | 8 weeks | measured by BECK Anxiety Inventory (BAI) |
| Depression | 8 weeks | measured by The Center for Epidemiologic Studies Depression (CES-D) |
Countries
Canada
Contacts
Primary ContactFaly Golshan, PhD Candidate
Backup ContactMarla Mickleborough, PhD
Outcome results
None listed